- Home
- BRKR
BRKR
Bruker Corporation
as 11-21-2024 10:32am EST
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
| Founded: | 1991 | Country: | United States |
| Employees: | N/A | City: | BILLERICA |
| Market Cap: | 7.5B | IPO Year: | 2000 |
| Target Price: | $77.45 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 2.06 | EPS Growth: | -4.69 |
| 52 Week Low/High: | $48.07 - $94.86 | Next Earning Date: | 11-05-2024 |
| Revenue: | $3,241,300,000 | Revenue Growth: | 15.00% |
| Revenue Growth (this year): | 15.4% | Revenue Growth (next year): | 7.78% |
Latest Bruker Corporation News
BRKR Breaking Stock News: Dive into BRKR Ticker-Specific Updates for Smart Investing
GuruFocus.com
a day ago
Bruker Stock Explodes 10.5% After CEO's $5M Insider Bet
Argus Research
a day ago
Daily – Vickers Top Buyers & Sellers for 11/20/2024
MT Newswires
2 days ago
Bruker Insider Bought Shares Worth $5,014,069, According to a Recent SEC Filing
Business Wire
3 days ago
Bruker Announces Quarterly Dividend
Simply Wall St.
7 days ago
Bruker's (NASDAQ:BRKR) Problems Go Beyond Weak Profit
Argus Research
9 days ago
BRKR: Lowering target price to $45.00
GlobeNewswire
9 days ago
Dragonfly Energy and Bruker Partner to Accelerate Battery Technology Development
Business Wire
9 days ago
Bruker Corporation to Present at Upcoming Investor Conferences
Compare BRKR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BRKR Bruker Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.